Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Innovation Pharmaceuticals Inc IPIX

Healthcare Biotechnology
Innovation Pharmaceuticals Inc. is a clinical stage pharmaceutical company developing therapies with anti-infective, oncology, anti-inflammatory and dermatology applications. The Company’s lead drug candidate, Brilacidin, is in a class of compounds called defensin-mimetics, small compounds that mimic the structure and function of defensins, also known as host defense peptides. The Company is... see more

GREY:IPIX - Post Discussion

Innovation Pharmaceuticals Inc > Looks to me
View:
Post by Brito1 on Aug 21, 2018 6:49pm

Looks to me

that the next news release will be yay or nay to Breakthrough Therapy Designation. if IPIX concluded data Analysis of it's phase 2 clinical trial May 9th and submitted for the Designation sometime in the following 6 weeks? then end of August at the latest would be the 60 day response time from the FDA. Of course it may have taken longer than 6 weeks to submit but not much. What do you guys and gals think?
Comment by aragon1959 on Aug 22, 2018 6:55am
agree with you Brito I wouldnt be surprise ,if with BTD comes  offer /partnership / acquisition by BP Its 2-4 Bln $ / year market and growing  GLTA
Comment by Brito1 on Aug 22, 2018 2:47pm
Looking for partnership not acquisition at this time as I believe we would be severely short changed.
Innovation Pharmaceuticals Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities